Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Des clients europeens ont rapporte des resultats faussement positifs. une erreur d'etiquetage s'est produite a la fabrication entrainant nversion de certains flacons de reactifs r1b (anticorps monoclonal anti-influenza b) et r2 (controle negatif).